BINEX Co., Ltd. (KOSDAQ:053030)

BINEX Revenue

BINEX had revenue of 37.81B KRW in the quarter ending June 30, 2026, a decrease of -15.09%. This brings the company's total for the last twelve months to 157.28B, up 2.68% year-over-year. In the year 2025, BINEX had annual revenue of 168.47B with 29.55% growth. That makes BINEX the 21,343rd largest company in the world by revenue and 1,165th in South Korea.

• Revenue (ttm): 157.28B
• Revenue Growth: +2.68%
• P/S Ratio: 1.25
• Revenue / Employee: 218.45M
• Employees: 720
• Market Cap: 196.82B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals 86.79B 51.5%
• Bio 81.68B 48.5%

By Geography

Chart

• South Korea 165.15B 98.0%
• Export 3.32B 2.0%

Fiscal year ended Dec 31, 2025 See the full BINEX breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	168.47B	38.42B	29.55%
Dec 31, 2024	130.05B	-24.77B	-16.00%
Dec 31, 2023	154.82B	-1.85B	-1.18%
Dec 31, 2022	156.68B	22.28B	16.58%
Dec 31, 2021	134.40B	1.42B	1.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error